<SEC-DOCUMENT>0001178913-24-001246.txt : 20240408
<SEC-HEADER>0001178913-24-001246.hdr.sgml : 20240408
<ACCEPTANCE-DATETIME>20240408092809
ACCESSION NUMBER:		0001178913-24-001246
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240408
DATE AS OF CHANGE:		20240408
GROUP MEMBERS:		M. ARKIN DERMATOLOGY LTD.

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sol-Gel Technologies Ltd.
		CENTRAL INDEX KEY:			0001684693
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90328
		FILM NUMBER:		24828335

	BUSINESS ADDRESS:	
		STREET 1:		7 GOLDA MEIR ST.
		STREET 2:		WEIZMANN SCIENCE PARK
		CITY:			NESS ZIONA
		STATE:			L3
		ZIP:			7403648
		BUSINESS PHONE:		97289313433

	MAIL ADDRESS:	
		STREET 1:		7 GOLDA MEIR ST.
		STREET 2:		WEIZMANN SCIENCE PARK
		CITY:			NESS ZIONA
		STATE:			L3
		ZIP:			7403648

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arkin Moshe
		CENTRAL INDEX KEY:			0001321178
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	MAIL ADDRESS:	
		STREET 1:		6 HACHOSHLIM ST.
		CITY:			HERZELIA
		STATE:			L3
		ZIP:			4672406
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>zk2431257.htm
<DESCRIPTION>SC 13D/A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <font style="font-size: 14pt;"><br>
      </font></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">WASHINGTON D.C. 20549</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SCHEDULE 13D</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">UNDER THE SECURITIES ACT OF 1934</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Amendment No. 4)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">Sol-Gel Technologies Ltd.</div>
    <div style="text-align: center; line-height: 1.25;">(Name of Issuer)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zea7b8ca96f3345e0a4999f104d9de007">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Ordinary Shares, par value NIS 0.1 per share</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">M8694L103</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">(Title of class of securities)</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">(CUSIP number)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">M. Arkin Dermatology Ltd.</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">6 HaChoshlim&#160;St., Bldg. C,</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Herzliya 46724, Israel</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Attn: Moshe Arkin</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Telephone: 972-9-7883333</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">with a copy to:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Goldfarb Gross Seligman &amp; Co.</div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">One Azrieli Center</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Tel Aviv 6701101, Israel<br>
      Attn:&#160; Perry Wildes, Adv.<br>
      &#160;Telephone: 972-3-607-4444</div>
    <div style="line-height: 1.25;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; line-height: 1.25;">&#160;(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">
      <div style="line-height: 1.25; font-weight: bold;">
        <div style="line-height: 1.25; font-weight: bold;">April 19, 2024</div>
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25;">(Date of Event Which Requires Filing of This Statement)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13(d)-1(e),
      13d-1(f) or 13d-1(g), check the following box <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;.</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><font style="font-style: italic;">Note</font>:&#160; Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.&#160;&#160;<font style="font-style: italic;">See</font>&#160;Section








      240.13d-7 for other parties to whom copies are to be sent.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">*The remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
      information which would alter disclosures provided in a prior cover page.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange
        Act of 1934 (&#8220;Act&#8221;) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).</div>
      <div style="line-height: 1.25;"> <br>
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25;">(Continued on following pages)</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><font style="font-weight: bold;">CUSIP No. M8694L103</font>&#160;</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z82e0c1f6de174009b957c37c5ea20648">

        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NAME OF REPORTING PERSONS&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><font style="font-weight: bold;">M.</font>&#160;<font style="font-weight: bold;">Arkin Dermatology Ltd.</font></div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">I.R.S. IDENTIFICATION NO.</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">OR ABOVE PERSON (ENTITIES ONLY):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(a)&#160; &#9744;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(b)&#160; &#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">3</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SEC Use Only&#160;<br>
              &#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOURCE OF FUNDS:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">WC</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">5</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e):</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CITIZENSHIP OR PLACE OF ORGANIZATION:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Israel</div>
          </td>
        </tr>
        <tr>
          <td rowspan="4" style="width: 19.49%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NUMBER OF</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARES</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">BENEFICIALLY</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">OWNED BY</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">EACH</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">REPORTING</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERSON WITH</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
          </td>
          <td style="width: 8.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">7</div>
          </td>
          <td style="width: 72%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE VOTING POWER:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">8</div>
          </td>
          <td style="width: 72%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED VOTING POWER:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
              <div style="line-height: 1.25; font-weight: bold;">
                <div style="line-height: 1.25; font-weight: bold;">18,068,564&#160; (*)</div>
              </div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">9</div>
          </td>
          <td style="width: 72%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE DISPOSITIVE POWER:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">10</div>
          </td>
          <td style="width: 72%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED DISPOSITIVE POWER:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">
                <div style="line-height: 1.25; font-weight: bold;">
                  <div style="line-height: 1.25; font-weight: bold;">18,068,564&#160; (*)</div>
                </div>
              </div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">11</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
              <div style="line-height: 1.25; font-weight: bold;">
                <div style="line-height: 1.25; font-weight: bold;">18,068,564&#160; (*)</div>
              </div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">12</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">13</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">
                <div style="line-height: 1.25; font-weight: bold;">60.52% (**)</div>
              </div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">14</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">TYPE OF REPORTING PERSON:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CO</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">(*) The beneficial ownership of the securities reported herein is described in Items 5(a) and (b).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25;">(**) Based on 27,857,620 Ordinary Shares outstanding on March 1, 2024 reported by Sol-Gel in its Annual Report on Form 20-F filed on March 13, 2024. As of April 19, 2023, this beneficial ownership percentage was
        approximately 60.8% based on (i) 25,695,458 Ordinary Shares outstanding on March 1, 2023 reported by Sol-Gel Technologies Ltd. in its Annual Report on Form 20-F filed on March 10, 2023 plus (ii) 2,000,000 Ordinary Shares and warrants to purchase up
        to 2,000,000 ordinary shares issued on April 19, 2023 to Arkin Dermatology Ltd., as described in Item 3. </div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-weight: bold;">CUSIP No. M8694L103</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z47a92737922c4fb2a2811a38074494c9">

        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">1</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NAME OF REPORTING PERSONS&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Moshe Arkin</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">I.R.S. IDENTIFICATION NO.</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">OR ABOVE PERSON (ENTITIES ONLY):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(a)&#160; &#9744;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(b)&#160; &#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">3</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; background-color: rgb(204, 238, 255); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SEC Use Only&#160;<br>
              &#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOURCE OF FUNDS:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">OO</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">5</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e):</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">6</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CITIZENSHIP OR PLACE OF ORGANIZATION:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Israel</div>
          </td>
        </tr>
        <tr>
          <td rowspan="4" style="width: 19.49%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NUMBER OF</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARES</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">BENEFICIALLY</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">OWNED BY</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">EACH</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">REPORTING</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERSON WITH</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
          </td>
          <td style="width: 8.39%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">7</div>
          </td>
          <td style="width: 72.12%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE VOTING POWER:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
              <div style="line-height: 1.25; font-weight: bold;">86,000 (*)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.39%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">8</div>
          </td>
          <td style="width: 72.12%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED VOTING POWER:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
              <div style="line-height: 1.25; font-weight: bold;">
                <div style="line-height: 1.25; font-weight: bold;">18,068,564&#160;(*)</div>
              </div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.39%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">9</div>
          </td>
          <td style="width: 72.12%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE DISPOSITIVE POWER:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
              <div style="line-height: 1.25; font-weight: bold;">86,000 (*)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.39%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">10</div>
          </td>
          <td style="width: 72.12%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED DISPOSITIVE POWER:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
              <div style="line-height: 1.25; font-weight: bold;">18,068,564 (*)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">11</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
              <div style="line-height: 1.25; font-weight: bold;">
                <div style="line-height: 1.25; font-weight: bold;">18,154,564 (*)</div>
              </div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">12</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">13</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
              <div style="line-height: 1.25; font-weight: bold;">60.8% (**)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.49%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">14</div>
          </td>
          <td colspan="2" style="width: 80.51%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">TYPE OF REPORTING PERSON:</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">IN</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    (*) The beneficial ownership of the securities reported herein is described in Items 5(a) and (b).
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25;">(**) Based on 27,857,620 Ordinary Shares outstanding on March 1, 2024 reported by Sol-Gel in its Annual Report on Form 20-F filed on March 13, 2024. As of April 19, 2023, this beneficial ownership percentage was
        approximately 61.1% based on (i) 25,695,458 Ordinary Shares outstanding on March 1, 2023 reported by Sol-Gel Technologies Ltd. in its Annual Report on Form 20-F filed on March 10, 2023 plus (ii) 2,000,000 Ordinary Shares and warrants to purchase up
        to 2,000,000 ordinary shares issued on April 19, 2023 to Arkin Dermatology Ltd., as described in Item 3.</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="background-color: #FFFFFF; line-height: 1.25;">
      <div style="background-color: #FFFFFF; line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
          <div style="text-align: justify; line-height: 1.25;">
            <div style="text-align: left; line-height: 1.25;">
              <div style="text-align: justify; line-height: 1.25; text-indent: 27pt;">The Amendment No. 4 to Schedule 13D is being filed by Arkin Dermatology Ltd. and Moshe Arkin (collectively, the &#8220;Reporting Persons&#8221;) and amends the Schedule 13D filed on
                February 12, 2018, as amended on August 21, 2018,April 20, 2020 and March 20, 2023, related to Ordinary Shares, par value NIS $0.1 per share (the "<u>Ordinary Shares</u>"), of Sol-Gel Technologies Ltd., a company organized under the laws of
                the State of Israel ("<u>Sol-Gel</u>"), The agreement among the Reporting Persons relating to the joint filing of this Schedule 13D is attached as an exhibit hereto.</div>
            </div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Item 3. Source and Amount of Funds or Other Consideration.</div>
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;"><br style="line-height: 1.25;">
              </div>
            </div>
            <div style="line-height: 1.25; text-indent: 27pt;">Item 3 of Schedule 13D is hereby amended to add the following paragraph:</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="line-height: 1.25; text-indent: 27pt;">On April 19, 2023, Sol-Gel and Arkin Dermatology Ltd. closed the transactions contemplated by the previously announced subscription agreement, dated January 27, 2023, between the parties,
              pursuant to which Arkin Dermatology Ltd. purchased 2,000,000 unregistered Ordinary Shares &#160;at a price of $5.00 per ordinary share and unregistered warrants to purchase up to 2,000,000 ordinary shares in a private placement&#160; exempt from the
              registration of the Securities Act of 1933.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Item 5. Interest in Securities of the Issuer.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Item 5 of Schedule 13D is hereby amended and restated as follows:</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(a) and (b)</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">As of April 3, 2024, Arkin Dermatology owned directly (and therefore is deemed the beneficial owner of) 18,068,564 Ordinary Shares, which
              represented beneficial ownership of approximately 60.52% of the Company&#8217;s outstanding Ordinary Shares.&#160; Arkin Dermatology has the shared power to vote, or direct the voting of, and the shared power to dispose of, or direct the disposition of,
              the Ordinary Shares held by Arkin Dermatology.</div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">As of April 3, 2024, Mr. Arkin owned directly (and therefore is deemed the beneficial owner of) 86,000 Ordinary Shares, which represented
              beneficial ownership of approximately 0.31% of the Company&#8217;s outstanding Ordinary Shares.&#160; Mr. Arkin has the sole power to vote, or direct the voting of, and the sole power to dispose of, or direct the disposition of, these Ordinary Shares.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">In addition, as the sole shareholder and sole director of Arkin Dermatology, Mr. Arkin may be deemed to be the indirect beneficial owner of the
              18,068,564 Ordinary Shares beneficially owned by Arkin Dermatology, which represented beneficial ownership of approximately 60.52% of the Company&#8217;s outstanding Ordinary Shares.&#160; Mr. Arkin has the shared power to vote, or direct the voting of,
              and the shared power to dispose of, or direct the disposition of, the Ordinary Shares held by Arkin Dermatology.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
              <div style="text-indent: 28.35pt; line-height: 1.25;">The total Ordinary Shares beneficially owned by Mr. Arkin as of January 31, 2023 is 18,154,564 which as of March 1, 2024, represented&#160; beneficial ownership of 60.8% of the Company&#8217;s
                outstanding Ordinary Shares.</div>
            </div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(c)&#160;&#160;Except as set forth in this Schedule 13D, to the best knowledge of the Reporting Persons, none of the Reporting Persons has beneficial
              ownership of, or has engaged in any transaction during the past 60 days in respect of, any Ordinary Shares.</div>
            <div style="line-height: 1.25;"> <br>
            </div>
            <div style="line-height: 1.25;"> </div>
          </div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="text-indent: 28.35pt; line-height: 1.25;">(d)&#160; No person, other than the Reporting Persons, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Ordinary Shares referred to
        in this Item 5.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 28.35pt; line-height: 1.25;">
        <div style="line-height: 1.25;">Percentages set forth in this amended Schedule 13D were calculated based on 27,857,620 Ordinary Shares outstanding on March 1, 2024. Figures were provided by the Issuer.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Item 7. Material to be Filed as Exhibits.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">The following Exhibits are filed herewith:</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zaa45c06e60e44f94bf7d133623accb7c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Joint Filing Agreement, dated as of February 12, 2018, by and among the Reporting Persons (incorporated by reference to Exhibit 1 to the Original Schedule 13D).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" id="z0f051b0ed70b405baf4f71ef2e0ff577" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="vertical-align: top; width: 18pt;">
                <div style="text-align: justify; line-height: 1.25;">2.</div>
              </td>
              <td style="vertical-align: top; width: auto;">
                <div style="text-align: justify; line-height: 1.25;">Board resolution of M. Arkin Dermatology Ltd. (incorporated by reference to Exhibit 2 to the Original Schedule 13D).</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zb8b8d6ef233647f9b9344549ea23c383" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Form of Warrant (incorporated by reference to Exhibit 4.1 of the Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on January 31, 2023).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1486e1523a674ba788a5a41e9f68f078" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Form of Subscription Agreement (incorporated by reference to Exhibit 10.2 of the Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on January 31, 2023).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" id="z94b720702ce34ebda225c2100d4898f1" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="vertical-align: top; width: 18pt;">
                <div style="text-align: justify; line-height: 1.25;">5.</div>
              </td>
              <td style="vertical-align: top; width: auto;">
                <div style="text-align: justify; line-height: 1.25;">Form of Registration Rights Agreement (incorporated by reference to Appendix A of Exhibit 99.1 of Sol-Gel&#8217;s Form 6-K filed with the Securities and Exchange Commission on March 1, 2023.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Signatures</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25;">After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zef99a44ccb2e438792e90c97cf359db8">

        <tr>
          <td style="width: 100%; vertical-align: middle;">
            <div style="line-height: 1.25; font-weight: bold;">
              <div style="line-height: 1.25;"><font style="font-weight: bold;">Dated</font>: <font style="font-weight: normal;">April 8, 2024</font></div>
              <div style="line-height: 1.25">&#160;</div>
            </div>
            <div style="line-height: 1.25; font-weight: bold;">M. Arkin Dermatology Ltd.</div>
            <div style="line-height: 1.25;">&#160;</div>
            <div style="line-height: 1.25;"><u>/s/ Moshe Arkin</u></div>
            <div style="line-height: 1.25;">Name: Moshe Arkin</div>
            <div style="line-height: 1.25;">Title: Director</div>
            <div style="line-height: 1.25;">&#160;</div>
            <div style="line-height: 1.25; font-weight: bold;">Moshe Arkin</div>
            <div style="line-height: 1.25; font-weight: bold;">&#160;</div>
            <div style="line-height: 1.25;"><u>/s/ Moshe Arkin</u></div>
            <div style="line-height: 1.25;">Name: Moshe Arkin</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font class="BRPFPageNumber" style="color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">6</font>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
